Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLAT-STEMI: Early vs Provisional Clotinab in STEMI
NCT00841438Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jul 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of clopidogrel in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Yonsei University. Primary endpoint: Major Adverse Cardiac and Cerebrovascular Events at 30 days. Started Jul 2007; status: completed.
02
Drugs
clopidogrel
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00841438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841438.